carbamates has been researched along with plx8394 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Adelmann, CH; Bansal, V; Ching, G; Du, L; Lee, W; Liang, R; Pence, LJ; Saporito, RC; Tsai, KY | 1 |
Enzler, F; Feichtner, A; Fleischmann, J; Hartl, M; Huber, RG; Mayrhofer, JE; Ogris, E; Raffeiner, A; Röck, R; Schneider, R; Stefan, E; Torres-Quesada, O; Troppmair, J; Tschaikner, P | 1 |
2 other study(ies) available for carbamates and plx8394
Article | Year |
---|---|
Comparative profiles of BRAF inhibitors: the paradox index as a predictor of clinical toxicity.
Topics: Apoptosis; Carbamates; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Enzyme Activation; Heterocyclic Compounds, 2-Ring; Humans; Imidazoles; Indoles; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Vemurafenib | 2016 |
Mutation-oriented profiling of autoinhibitory kinase conformations predicts RAF inhibitor efficacies.
Topics: A549 Cells; Carbamates; Heterocyclic Compounds, 2-Ring; Humans; Imidazoles; Lung Neoplasms; Mutation; Oximes; Phosphotransferases; Protein Conformation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins B-raf; Sulfonamides; Vemurafenib | 2020 |